DK457583D0 - Fremgangsmade til fremstilling af dihydropyrazolo(3,4-b)pyridin-derivater - Google Patents

Fremgangsmade til fremstilling af dihydropyrazolo(3,4-b)pyridin-derivater

Info

Publication number
DK457583D0
DK457583D0 DK4575/83A DK457583A DK457583D0 DK 457583 D0 DK457583 D0 DK 457583D0 DK 4575/83 A DK4575/83 A DK 4575/83A DK 457583 A DK457583 A DK 457583A DK 457583 D0 DK457583 D0 DK 457583D0
Authority
DK
Denmark
Prior art keywords
dihydropyrazolo
preparing
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
DK4575/83A
Other languages
English (en)
Other versions
DK457583A (da
DK160278C (da
DK160278B (da
Inventor
Ikuo Adaki
Teruo Yamamori
Motohiko Ueda
Hatsuo Sato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK457583D0 publication Critical patent/DK457583D0/da
Publication of DK457583A publication Critical patent/DK457583A/da
Publication of DK160278B publication Critical patent/DK160278B/da
Application granted granted Critical
Publication of DK160278C publication Critical patent/DK160278C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK457583A 1982-10-05 1983-10-04 Analogifremgangsmaade til fremstilling af dihydropyrazolo(3,4-b)-pyridinderivater DK160278C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17676382 1982-10-05
JP57176763A JPS5965089A (ja) 1982-10-05 1982-10-05 ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法

Publications (4)

Publication Number Publication Date
DK457583D0 true DK457583D0 (da) 1983-10-04
DK457583A DK457583A (da) 1984-04-06
DK160278B DK160278B (da) 1991-02-18
DK160278C DK160278C (da) 1991-07-22

Family

ID=16019382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457583A DK160278C (da) 1982-10-05 1983-10-04 Analogifremgangsmaade til fremstilling af dihydropyrazolo(3,4-b)-pyridinderivater

Country Status (8)

Country Link
EP (1) EP0107619B1 (da)
JP (1) JPS5965089A (da)
KR (1) KR900006448B1 (da)
AU (1) AU568092B2 (da)
DE (1) DE3372770D1 (da)
DK (1) DK160278C (da)
ES (1) ES525668A0 (da)
GB (1) GB2128186B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd 4,7―ジヒドロピラゾロ[3,4―b]ピリジン誘導体とその製造法
GR79111B (da) * 1982-12-20 1984-10-02 Lepetit Spa
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd 4,7−ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
JPS60246387A (ja) * 1984-05-22 1985-12-06 Yoshitomi Pharmaceut Ind Ltd ジヒドロイミダゾ〔1,2−a〕ピリミジン誘導体
JPS6210087A (ja) * 1985-07-03 1987-01-19 Shionogi & Co Ltd 4,7−ジヒドロチエノ〔2,3−b〕ピリジン誘導体,その製造法および循環器系疾患治療剤
EP0355234A1 (en) * 1988-08-25 1990-02-28 Merrell Dow Pharmaceuticals Inc. Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents
JP2001503762A (ja) * 1996-11-12 2001-03-21 ノバルティス アクチェンゲゼルシャフト 除草剤として有用なピラゾール誘導体
CA2437215A1 (en) * 2001-02-02 2002-08-15 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
WO2004002531A1 (ja) * 2002-06-26 2004-01-08 Ono Pharmaceutical Co., Ltd. 血管の収縮または拡張による疾患治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857849A (en) * 1973-02-28 1974-12-31 Bayer Ag 2-amino-1,4-dihydropyridine derivatives
GR79111B (da) * 1982-12-20 1984-10-02 Lepetit Spa

Also Published As

Publication number Publication date
ES8502993A1 (es) 1985-02-01
DE3372770D1 (en) 1987-09-03
ES525668A0 (es) 1985-02-01
KR900006448B1 (ko) 1990-08-31
GB2128186B (en) 1986-04-30
AU1990283A (en) 1984-04-12
EP0107619A1 (en) 1984-05-02
EP0107619B1 (en) 1987-07-29
DK457583A (da) 1984-04-06
GB8325024D0 (en) 1983-10-19
JPH036151B2 (da) 1991-01-29
KR840006482A (ko) 1984-11-30
JPS5965089A (ja) 1984-04-13
GB2128186A (en) 1984-04-26
DK160278C (da) 1991-07-22
DK160278B (da) 1991-02-18
AU568092B2 (en) 1987-12-17

Similar Documents

Publication Publication Date Title
DK25081A (da) Fremgangsmaade til fremstilling af imidazo(1,2-a) pyridiner
DK138281A (da) Fremgangsmaade til fremstilling af 3-(1-piperidinylalkyl)-4h-pyrido (1,2-a) pyrimidin-4-on-derivater
DK470583D0 (da) Fremgangsmade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK161325C (da) Analogifremgangsmaade til fremstilling af imidazooe4,5-caa-pyridinderivater
DK89783D0 (da) Fremgangsmade til fremstilling af 3-keto-delta4,9-19-nor-steroidderivater
DK214685D0 (da) Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner
DK492783D0 (da) Fremgangsmade til fremstilling af 3-aryl-5-pyrazol-derivater
DK95483D0 (da) Fremgangsmade til fremstilling af tetrahydropyranderivater
DK173983D0 (da) Fremgangsmade til fremstilling af imidazo (1,2-alfa)pyridiner
DK194183D0 (da) Fremgangsmade til fremstilling af 2-phenyl-imidazo(4,5-c)pyridiner
DK143491A (da) Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion
DK210083D0 (da) Fremgangsmade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
DK262782A (da) Fremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK457583A (da) Fremgangsmaade til fremstilling af dihydropyrazolo(3,4-b)pyridin-derivater
DK123183D0 (da) Fremgangsmade til fremstilling af pyridinderivater
DK277682A (da) Fremgangsmaade til fremstilling af substituerede imidazo (1,5-a)pyridiner eller salte deraf
AR229600A1 (es) Procedimiento para preparar derivados de 1,2,3-triazolo(4,5-b)(1,5)benzodiazepina
DK113483A (da) Fremgangsmaade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
DK154207C (da) Fremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner
FI834410A7 (fi) Menetelmä pyrimidinonijohdannaisten valmistamiseksi.
DK253382A (da) Fremgangsmaade til fremstilling af 1,4,9,10-tetrahydro-pyrazolo(4,3-e)pyrido(3,2-b)(1,4)diazepin-10-oner
DK161706C (da) Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner
DK188881A (da) Fremgangsmaade til fremstilling af 2-guanidinthiazol-derivater
DK159681C (da) Fremgangsmaade til fremstilling af 2-substituerede 5-nitroso-4,6-diamino-pyrimidiner
DK288079A (da) Fremgangsmaade til fremstilling af imidazolylethoxyderivater af pyrazolo (3,4-b) pyridin-5-methanoler